Ipca Laboratories (NSE:IPCALAB) Institutional Ownership: 46.39% (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:IPCALAB Ipca Laboratories Ltd NSE:IPCALAB
92 GF Score
Price ₹1,900.60
GF Value ₹1,596.57
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Ipca Laboratories Institutional Ownership?

Ipca Laboratories NSE:IPCALAB +0.55% 92 Institutional Ownership is 46.39% as of Jul. 19, 2026. GuruFocus rates NSE:IPCALAB with a GF Score™ of 92/100 and a GF Value™ of ₹1,596.57 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ipca Laboratories's institutional ownership is 46.39%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ipca Laboratories's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ipca Laboratories's Float Percentage Of Total Shares Outstanding is 0.00%.

Ipca Laboratories Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Ipca Laboratories's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipca Laboratories Institutional Ownership Chart

Ipca Laboratories Historical Data

The historical data trend for Ipca Laboratories can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 46.04 46.13 46.49 44.98 46.43 46.83 46.76 46.64 46.41 46.39
NSE:IPCALAB
92GF Score
Ipca Laboratories Ltd NSE:IPCALAB
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ipca Laboratories Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 46.39% mean?
Ipca Laboratories (NSE:IPCALAB) has a Institutional Ownership of 46.39% as of Jul. 19, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Ipca Laboratories and its competitors.
Is Ipca Laboratories' Institutional Ownership too high?
Ipca Laboratories' current Institutional Ownership is 46.39%. Overall, Ipca Laboratories has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ipca Laboratories' Institutional Ownership compare to ZTS and UTHR?
Ipca Laboratories' Institutional Ownership of 46.39% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Ipca Laboratories and its competitors. Ipca Laboratories's current Institutional Ownership is 46.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ipca Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ipca Laboratories (NSE:IPCALAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,596.57, compared to a current price of ₹1,900.60 — trading 19% above its estimated fair value. The current Institutional Ownership is 46.39%. Ipca Laboratories' overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Ipca Laboratories (NSE:IPCALAB), the current Institutional Ownership is 46.39% as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ipca Laboratories (NSE:IPCALAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ipca Laboratories stock appears to be overvalued. The current stock price of ₹1,900.60 is trading 19% above its estimated GF Value™ of ₹1,596.57. GuruFocus considers Ipca Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:IPCALAB:

  • Institutional Ownership: 46.39%
  • GF Value™: ₹1,596.57 vs. price of ₹1,900.60 (19% above fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the NSE:IPCALAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ipca Laboratories Business Description

Other Exchanges 524494:India
Address No. 48, 123 AB, 125 & 126 Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
92GF Score

Get the complete analysis for NSE:IPCALAB

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,900.60
Price
₹1,596.57
GF Value